Skip to main content
XCUR
NASDAQ Life Sciences

Director Resigns Amidst Going Concern Doubts

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4
Mkt Cap
$28.141M
52W Low
$3.101
52W High
$14.73
52W Position info
29% above low
Off High info
73% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

XCUR sits 29% above its 52-week low of $3.101.

Summary

Sangjin Yeo has resigned from Exicure's Board of Directors and Audit Committee, effective March 27, 2026, following the company's recent disclosure of going concern doubts.


Key Events · Executive and Board Changes · XCUR

  • Director Resignation

    Sangjin Yeo resigned from the Board of Directors and the Audit Committee, effective March 27, 2026.

  • No Disagreement Stated

    The company stated that the resignation was not due to any disagreement regarding operations, policies, or practices.

  • Follows Going Concern Warning

    This departure comes shortly after the company disclosed a critical cash position and substantial doubt about its ability to continue as a going concern in its recent 10-K filing on March 25, 2026.


Analysis · XCUR · Life Sciences

The resignation of Sangjin Yeo from the Board of Directors and Audit Committee, while stated not to be due to disagreements, occurs just two days after Exicure, Inc. reported significant doubt about its ability to continue as a going concern and a critical cash position. In a financially distressed company, any change in governance, even if routine, can be perceived as adding to instability and uncertainty. Investors will monitor future board compositions and any further executive changes closely.

At the time of this filing, XCUR was trading at $4.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28.1M. The 52-week trading range was $3.10 to $14.73. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Jul 17, 2026, 4:39 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $1.74 info
Change: +$0.110 (+7%) info
Market Cap: $11.091M info
XCUR
Jul 17, 2026, 1:05 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $1.74 info
Change: +$0.075 (+5%) info
Market Cap: $11.091M info
XCUR
Jun 30, 2026, 3:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.74 info
Change: -$0.2616 (-13%) info
Market Cap: $11.091M info
XCUR
Jun 30, 2026, 2:55 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.03
Real-time Price: $1.74 info
Change: -$0.290 (-14%) info
Market Cap: $11.091M info
XCUR
May 29, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.16
Real-time Price: $1.74 info
Change: -$1.42 (-45%) info
Market Cap: $11.091M info